148
Views
12
CrossRef citations to date
0
Altmetric
Article

The Effects of Curcumin on Serum Heat Shock Protein 27 Antibody Titers in Patients with Metabolic Syndrome

, MSc, , MSc, , MD, PhD, , PhD, , Cardiologist, , PhD, , MSc, , MSc, , DSc, MD, FRCP & , PhD show all

References

  • Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. 2009. Harmonizing the metabolic syndrome a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 120:1640–5. doi:10.1161/CIRCULATIONAHA.109.192644. PMID: 19805654.
  • Al-Omar FA, Nagi MN, Abdulgadir MM, Al Joni KS, Al-Majed AA. 2006. Immediate and delayed treatments with curcumin prevents forebrain ischemia-induced neuronal damage and oxidative insult in the rat hippocampus. Neurochemical research. 31:611–8. doi:10.1007/s11064-006-9059-1. PMID: 16770732.
  • Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. 2007. Bioavailability of curcumin: problems and promises. Molecular pharmaceutics. 4:807–18. doi:10.1021/mp700113r. PMID: 17999464.
  • Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B, Tharakan ST, Misra K, Priyadarsini IK, Rajasekharan KN. 2008. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochemical pharmacology. 76:1590–611. doi:10.1016/j.bcp.2008.08.008. PMID: 18775680.
  • Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh S, Safarian M, Esmaeili H, Khodaei G, Kazemi-Bajestani SM, Hosseini SJ, Parizadeh SM, Jooya M. 2008. Metabolic syndrome: its prevalence and relationship to socio-economic parameters in an Iranian population. Nutrition, Metabolism and Cardiovascular Diseases. 18:e11–2. doi:10.1016/j.numecd.2007.07.005.
  • Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. 2003. Prevalence of metabolic syndrome in an urban population: tehran lipid and glucose study. Diabetes research and clinical practice. 61:29–37. doi:10.1016/S0168-8227(03)00066-4. PMID: 12849921.
  • Baum L, Ng A. 2004. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. Journal of Alzheimer's disease. 6:367–78. doi:10.3233/JAD-2004-6403. PMID: 15345806.
  • Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G. 2010. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev. 15:337–44. PMID: 21194249.
  • Daniel S, Limson JL, Dairam A, Watkins GM, Daya S. 2004. Through metal binding, curcumin protects against lead-and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain. Journal of inorganic biochemistry. 98:266–75. doi:10.1016/j.jinorgbio.2003.10.014. PMID: 14729307.
  • International Diabetes Federation. 2010. IDF worldwide definition of the metabolic syndrome.
  • Ferns GA. 2008. Multiple step-variable pathway hypothesis: a reason why predictions fail in atherosclerosis. Medical hypotheses. 71:923–6. doi:10.1016/j.mehy.2008.07.014. PMID: 18762385.
  • Fleiss JL. 2011. Design and analysis of clinical experiments. New York, United States: John Wiley & Sons.
  • Ghayour-Mobarhan M, Rahsepar A, Tavallaie S, Rahsepar S, Ferns G. 2009. The potential role of heat shock proteins in cardiovascular disease: evidence from in vitro and in vivo studies. Advances in clinical chemistry. 48:27–72. doi:10.1016/S0065-2423(09)48002-8. PMID: 19803414.
  • Ghayour‐Mobarhan M, Sahebkar A, Parizadeh SMR, Moohebati M, Tavallaie S, Kazemi‐Bajestani SMR, Esmaeili HA, Ferns G. 2008. Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. International journal of experimental pathology. 89:209–15. doi:10.1111/j.1365-2613.2008.00586.x. PMID: 18460073.
  • Goel A, Kunnumakkara AB, Aggarwal BB. 2008. Curcumin as “Curecumin”: from kitchen to clinic. Biochemical pharmacology. 75:787–809. doi:10.1016/j.bcp.2007.08.016. PMID: 17900536.
  • Grundy SM. 2008. Metabolic syndrome pandemic. Arteriosclerosis, Thrombosis, and Vascular Biology. 28:629–36. doi:10.1161/ATVBAHA.107.151092. PMID: 18174459.
  • Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr. 2005. Diagnosis and management of the metabolic syndrome an American heart association/national heart, lung, and blood institute scientific statement. Circulation. 112:2735–52. doi:10.1161/CIRCULATIONAHA.105.169404. PMID: 16157765.
  • Heidari-Bakavoli AR, Sahebkar A, Mobara N, Moohebati M, Tavallaie S, Rahsepar AA, Kazemi A, Alavi MS, Ghayour-Mobarhan M, Ferns GA. 2012. Changes in plasma level of heat shock protein 27 after acute coronary syndrome. Angiology. 63:12–16. doi:10.1177/0003319711406104. PMID: 21555305.
  • Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE. 2006. Dose escalation of a curcuminoid formulation. BMC complementary and alternative medicine. 6:10. doi:10.1186/1472-6882-6-10. PMID: 16545122.
  • McDowell MA, Fryar CD, and Flegal KM. 2008. Anthropometric reference data for children and adults: United States, 2003–2006. National health statistics reports. 10(1–45):5.
  • Mohammadi A, Sahebkar A, Iranshahi M, Amini M, Khojasteh R, Ghayour‐Mobarhan M, Ferns GA. 2013. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytotherapy Research. 27:374–9. doi:10.1002/ptr.4715. PMID: 22610853.
  • Panahi Y, Badeli R, Karami GR, Sahebkar A. 2015. Investigation of the efficacy of adjunctive therapy with bioavailability‐boosted curcuminoids in major depressive disorder. Phytotherapy Research. 29:17–21. doi:10.1002/ptr.5211. PMID: 25091591.
  • Panahi Y, Rahimnia AR, Sharafi M, Alishiri G, Saburi A, Sahebkar A. 2014. Curcuminoid treatment for knee osteoarthritis: a randomized double‐blind placebo‐controlled trial. Phytotherapy Research. 28:1625–31. doi:10.1002/ptr.5174. PMID: 24853120.
  • Panahi Y, Saadat A, Beiraghdar F, Sahebkar A. 2014. Adjuvant therapy with bioavailability‐boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double‐blind placebo‐controlled trial. Phytotherapy Research. 28:1461–7. doi:10.1002/ptr.5149. PMID: 24648302.
  • Panahi Y, Sahebkar A, Amiri M, Davoudi SM, Beiraghdar F, Hoseininejad SL, Kolivand M. 2012. Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. British Journal of Nutrition. 108:1272–9. doi:10.1017/S0007114511006544. PMID: 22099425.
  • Panahi Y, Sahebkar A, Parvin S, Saadat A. 2012. A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Annals of clinical biochemistry. 49:580–8. doi:10.1258/acb.2012.012040. PMID: 23038702.
  • Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. 2005. Recommendations for blood pressure measurement in humans and experimental animals part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 45:142–61. doi:10.1161/01.HYP.0000150859.47929.8e. PMID: 15611362.
  • Pourghadamyari H, Moohebati M, Parizadeh SMR, Falsoleiman H, Dehghani M, Fazlinezhad A, Akhlaghi S, Tavallaie S, Sahebkar A, Paydar R, et al. 2011. Serum antibody titers against heat shock protein 27 are associated with the severity of coronary artery disease. Cell Stress and Chaperones. 16:309–16. doi:10.1007/s12192-010-0241-7. PMID: 21107776.
  • Ross R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s.
  • Sahebkar A. 2014. Are curcuminoids effective c-reactive protein-lowering agents in clinical practice? evidence from a meta-analysis. Phytotherapy research. 28:633–42. doi:10.1002/ptr.5045. PMID: 23922235.
  • Sahebkar A. 2013. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? Biofactors. 39:197–208. doi:10.1002/biof.1062. PMID: 23239418.
  • Sahebkar A, Chew GT, Watts GF. 2014. Recent advances in pharmacotherapy for hypertriglyceridemia. Progress in lipid research. 56:47–66. doi:10.1016/j.plipres.2014.07.002. PMID: 25083925.
  • Sahebkar A, Mohammadi A, Atabati A, Rahiman S, Tavallaie S, Iranshahi M, Akhlaghi S, Ferns GA, Ghayour-Mobarhan M. 2013. Curcuminoids modulate pro‐oxidant–antioxidant balance but not the immune response to heat shock protein 27 and oxidized ldl in obese individuals. Phytotherapy research. 27:1883–8. doi:10.1002/ptr.4952. PMID: 23494802.
  • Sahebkar A, Pourghadamyari H, Moohebati M, Parizadeh SMR, Falsoleiman H, Dehghani M, Fazlinezhad A, Akhlaghi S, Tavallaie S, Paydar R. 2011. A cross-sectional study of the association between heat shock protein 27 antibody titers, pro-oxidant–antioxidant balance and metabolic syndrome in patients with angiographically-defined coronary artery disease. Clinical biochemistry. 44:1390–5. doi:10.1016/j.clinbiochem.2011.09.011. PMID: 21986591.
  • Semalty A, Semalty M, Rawat MSM, Franceschi F. 2010. Supramolecular phospholipids–polyphenolics interactions: the phytosome® strategy to improve the bioavailability of phytochemicals. Fitoterapia. 81:306–14. doi:10.1016/j.fitote.2009.11.001. PMID: 19919847.
  • Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas P. 1998. Influence of Piperine on the pharmacokinetics of curcumin in animals and human volunteers planta med. 64:353–6.
  • Tucker NR, Ustyugov A, Bryantsev AL, Konkel ME, Shelden EA. 2009. Hsp27 is persistently expressed in zebrafish skeletal and cardiac muscle tissues but dispensable for their morphogenesis. Cell Stress and Chaperones. 14:521–33. doi:10.1007/s12192-009-0105-1. PMID: 19238587.
  • Varalakshmi C, Ali AM, Pardhasaradhi B, Srivastava RM, Singh S, Khar A. 2008. Immunomodulatory effects of curcumin: in-vivo. International immunopharmacology. 8:688–700. doi:10.1016/j.intimp.2008.01.008. PMID: 18387511.
  • Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. 2005. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 112:3066–72. doi:10.1161/CIRCULATIONAHA.105.539528. PMID: 16275870.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.